CORCEPT THERAPEUTICS INC 4
4 · CORCEPT THERAPEUTICS INC · Filed Apr 21, 2004
Insider Transaction Report
Form 4
MARDUEL ALIX
Director10% Owner
Transactions
- Conversion
Common Stock
[F1]2004-04-19+1,698,274→ 1,698,274 total(indirect: See Remark) - Conversion
Series C Preferred Stock
[F2][F3][F1]2004-04-19−1,698,274→ 0 total(indirect: See Remarks)→ Common (1,698,274 underlying)
Footnotes (3)
- [F1]Not applicable
- [F2]Each Share is convertible without consideration into one (1) share of Common Stock.
- [F3]Immediately
Signature
/s/ Fred Kurland, CFO of Corcept Therapeutics Incorporated attorney-in-fact|2004-04-21